Personalis, Inc.

Personalis, Inc.

PSNL·NASDAQ

$10.78

-3.2%
HealthcareMedical - Diagnostics & Research

Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or plasma sample; ImmunoID Next for tumor profiling from tissue; NeXT Liquid Biopsy for tumor profiling from plasma; NeXT Personal, a liquid biopsy offering for personalized tumor tracking for patients; NeXT Dx Test, a genomic cancer profiling test enabling composite biomarkers for cancer treatment; and NeXT SHERPA and NeXT NEOPS for neoantigen prediction capabilities. The company also provides ACE platform for clinical and therapeutic applications such as neoantigen prediction, biomarker identification, and novel drug target selection. It serves biopharmaceutical customers, universities, non-profits, and government entities. The company has partnership with Mayo Clinic; MapKure, LLC; SpringWorks Therapeutics, Inc.; and Moores Cancer Center. Personalis, Inc. was incorporated in 2011 and is headquartered in Menlo Park, California.

At a Glance

Live Snapshot
Market Cap$957.31M
EPS-0.9100
P/E Ratio-11.85
Earnings Date08/04/2026

No Dividend Yield Data

PSNL has not reported any dividend yield values in the available annual periods.

No Dividend Payout Ratio Data

PSNL has not reported any dividend payout ratio values in the available annual periods.

No Net Dividends Paid Data

PSNL has not reported any net dividends paid values in the available annual periods.

Personalis, Inc.

Personalis, Inc. Dividend History

PSNL · NASDAQ
10Y CAGR +0%
Latest $0
Annual $0
Stable dividend payments
Last Period: +0%

PSNL Dividend Payment History

PSNL · NASDAQ
DeclarationEx-DatePayment DateDividendAdjustedFrequencyGrowth
No dividend payment history available
psnl

Personalis, Inc. Payout Ratio Analysis

PSNL · NASDAQ
Dividends Paid
0.00
2025
Net Income
-81.27M
2025
Payout Ratio
0.00%
2025

Dividend Sustainability Analysis

Payout Ratio
0.00%

Conservative payout with excellent safety margin. Company retains significant earnings for growth, acquisitions, or building cash reserves. Dividend is highly sustainable.

FCF Payout Ratio
0.0%

Negative free cash flow while paying dividends is a major red flag. Company burning cash and cannot sustain dividend without external financing.

Sustainability
At Risk

Dividend appears unsustainable based on current metrics. High probability of reduction or elimination. Proceed with caution.